01 · REVIEW
Individual medical evaluation
A licensed physician reviews your health history, current medications, goals, and relevant risk factors.
Program in development
Peptide therapy,
Peptide therapy,
guided by physicians.
NuvaMed is developing a physician-supervised peptide therapy program centered on careful medical review, transparent education, and ongoing support.
Treatment options have not yet been announced. Joining the list does not guarantee eligibility or a prescription.
Understanding peptides
What is peptide therapy?
Peptides are short chains of amino acids that act as signaling molecules throughout the body. Some peptide-based medicines have established clinical uses, while others remain investigational or are not FDA-approved. The evidence, potential benefits, risks, and regulatory status depend on the specific peptide.
02 · EDUCATION
Clear, evidence-aware guidance
You receive information about the specific therapy, including expected use, limitations, potential risks, and alternatives.
03 · SUPPORT
Ongoing clinical oversight
If treatment is appropriate and prescribed, follow-up care helps your clinician monitor safety and response.
A careful approach
Safety starts with the specific therapy.
“Peptides” describes a broad category—not one treatment. NuvaMed will publish details about specific options only after clinical, pharmacy, legal, and regulatory review. No medication is appropriate for everyone, and prescriptions are never guaranteed.
Important: Do not purchase or inject products labeled “research use only” for personal treatment. Always discuss any peptide product with a qualified healthcare professional.
Frequently asked questions
Peptide therapy FAQ
Which peptides will NuvaMed offer?
The treatment list has not yet been announced. We will update this page when specific therapies have completed NuvaMed's clinical and compliance review.
Is peptide therapy available now?
Not yet. The program is in development. Join the interest list to receive availability updates.
Does joining the list qualify me for treatment?
No. Joining only requests updates. If a program launches, eligibility and prescribing decisions will be made by a licensed physician after an individual medical evaluation.
Are all peptides FDA-approved?
No. Regulatory status varies by substance and intended use. Any future NuvaMed program information will identify the status and important limitations of the specific treatment discussed.
Be the first to know
Get peptide program updates.
Join the interest list and we’ll let you know when NuvaMed announces availability and treatment details.